> The British Society for Antimicrobial Chemotherapy (BSAC) OPAT Drug Stability Programme provides evidence and open access stability data on agents and devices used in infection management, particularly those used in Outpatient Parenteral Antimicrobial Therapy (OPAT) services.
> Guidance on Pharmaceutical Issues concerning OPAT Services and other Outpatient Intravenous Therapies: NHS OPAT Yellow Cover Document
> This is a case study on NHS Supply Chain: Value Based Procurement Pilot Reduces Length of Stay and Improves Patient Experience, which is based on the OUH experience.
> The following articles may be of interest if you are considering introducing elastomeric devices as a way of delivering IV antibiotics via OPAT services.
- Health economic assessment – OPAT vs inpatient care: Dimitrova et al 2021
- Challenges and opportunities of OPAT services: Chapman 2013
- Updated good practice recommendations for OPAT in UK: Chapman et al 2019
- How to develop a successful business case for OPAT services (United Lincolnshire Hospitals NHS Trust): Leo 2020
- Challenges and solutions to starting and managing OPAT services (USA based): Halilovic et al 2014
- The Comparing Home Infusion Devices (CHID) study (Australia based) : Hobbs et al 2017
- Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections: Mujal et al 2015 (abstract)
- Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people: Mujal et al 2016
- Optimising patient safety when using elastomeric pumps to administer outpatient parenteral antibiotic therapy: Oliver 2016 (abstract)